半乳糖凝集素-3与子宫内膜异位症

摘要
图/表
参考文献
相关文章 (11)

全文: PDF (287 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要半乳糖凝集素-3(Galectin-3)是半乳糖凝集素家族中唯一的嵌合型成员,在人体组织分布广泛,并在机体参与多种生理生化作用。Galectin-3在肿瘤的发生发展、侵袭转移、诱导细胞凋亡等方面发挥着重要作用。子宫内膜异位症是一种良性病变,但其生物学行为却与恶性肿瘤相似,如局部或远处的迁徙、黏附、侵袭、破坏其他组织的能力。因此,Galectin-3可能在具有类似肿瘤的“良性增生、恶性行为”的子宫内膜异位症中的发生发展中发挥着重要作用。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	石亚楠
	黄河玲

关键词 ：半乳糖凝集素-3, 子宫内膜异位症, 黏附, 侵袭

收稿日期: 2014-12-31

通讯作者: 黄河玲(hhl252@aliyun.com)

引用本文:

石亚楠, 黄河玲. 半乳糖凝集素-3与子宫内膜异位症[J]. 中国生育健康杂志, 2015, 26(6): 584-585.

链接本文:

http://cjrh.bjmu.edu.cn/CN/ 或 http://cjrh.bjmu.edu.cn/CN/Y2015/V26/I6/584

1 Hirabayashi J,Hashidate T,Arata Y,et a1.Oligosaccharide specificity of galectins:a search by frontal affinity chromatography.Biochim Biophys Acta,2002,1572:232-254.
2 Dumic J,Dabelic S,Flgel M.Galectin-3:an open-ended story.Biochim Biophys Acta,2006,1760:616-635 .
3 Takenaka Y,Fukumori T,Raz A.Galectin-3 and metastasis.Glycoconj J,2004,19:543-549.
4 Murray MJ,Lessey BA.Embryo implantation and tumor metasasis:common pathways of in vasion and angiogenesis.Semin Reprod Endocrinol,1999,17:275-290.
5 Hernandez JD,Baum LG.Ah,sweet mystery of death!Galectins and control of cell fate.Glycobiology,2002,12:127R-136R.
6 Cheung YF,Huang GY,Chen SB,et al.Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and its arterialsequelae.Pediatrics,2008,122:608-614.
7 Honjo Y,Nangia-Makker P,Inohara H,et al.Down-regulation of galectin-3 suppresses tumorigencity of human breast carcinoma cells.Clin cancer Res,2001,7:661-668.
8 Yoshii T,Fukumori T,Honjo Y,et al.Galectin-3 phosphorylation required for its anti-apoptotic function and cell cycle arrest.J Biol Chem,2002,277:6852-6857.
9 王启明,王进京,张杭.Galectin-3与Wnt信号分子β-catenin在结肠癌中的表达.川北医学学报,2012,27:195-200.
10 Parise LV,Lee J,Juliano RL.New aspects of integrin signaling in cancer.Semin Cancer Biol,2000,10:407-414.
11 Nangia-Makker P,Honjo Y,Sarvis R,et al.Galectin-3 induces endothelial cell morphogenesis and angiogenesis.Am J Pathol,2000,156:899-909.
12 Zucker S,cao J,Chen WT.Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.Oncogene,2000,19:6642-6650.
13 林敏,王沂峰.组织因子与子宫内膜异位症相关性的研究进展.中华妇产科杂志,2011,46:870-872.
14 郎景和.子宫内膜异位症的研究与设想.中华妇产科杂志,2003,38:590-592.
15 吕敬媛,庄国丽,卢北燕.Galectin-3、MMP-2蛋白在子宫内膜样腺癌中的表达及临床意义.黑龙江医药科学,2009,32:41-42.
16 张宇杰,卢美松.Galectin-3在子宫内膜息肉中的表达及意义.国际免疫学杂志,2012,35:320-322.
17 裴晓慧.Galectin-3,MMP-9在子宫腺肌病中的表达及意义.泰山医学院,2012:1-48.
18 Nakahars S,Oka N,Raz A.On the roal of galectin-3 in cancer apoptosis.Apoptosis,2005,10:267-275.
19 孙晓炜,张炜,周剑萍,等.galectin-3在子宫内膜异位症患者在位内膜中的表达及意义.中国免疫学杂志,2007,23:138-141.
20 Noel JC,Chapron C,Borghese B,et al.Galectin-3 is overexpressed in various forms of endometriosis.Appl Immunohistochem Mol Morphol,2011,19:253-257.
21 Michael W,Wang X,Gabius HJ ,et al.Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation.Molecular human reproduction,2005,11:189-194.